Medicus Pharma (MDCX) Other financing activities (2025)

Medicus Pharma (MDCX) reported Other financing activities of $69143.0 for Q4 2025, down 75.87% quarter-over-quarter from $286578.0 in Q3 2025.

Medicus Pharma (MDCX) Other financing activities (2025) Analysis & Trends

Medicus Pharma has reported Other financing activities for 1 years, with the latest figure at $69143.0 in Q4 2025.

For the quarter ending Q4 2025, Other financing activities changed N/A year-over-year to $69143.0; the trailing twelve-month figure through Dec 2025 stood at $195484.0 (changed N/A YoY), and the FY2025 full-year result was $653504.0, changed N/A from the prior year.
Other financing activities for Q4 2025 stood at $69143.0, down from $286578.0 in the prior quarter.
The five-year high for Other financing activities was $286578.0 in Q3 2025, with the low at -$185237.0 in Q2 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Gsk	92,316,836.42 Bn	92,316,831.46 Bn	7.76 Bn
2	Eli Lilly	983.57 Bn	978.29 Bn	16.22 Bn
3	Johnson & Johnson	553.56 Bn	531.50 Bn	15.96 Bn
4	AbbVie	383.35 Bn	374.00 Bn	10.78 Bn
5	Merck	281.71 Bn	276.06 Bn	12.09 Bn
6	Amgen	182.20 Bn	170.16 Bn	5.87 Bn
7	Gilead Sciences	153.71 Bn	145.98 Bn	5.52 Bn
8	Pfizer	143.75 Bn	130.98 Bn	-1.21 Bn
9	Bristol Myers Squibb	109.71 Bn	99.25 Bn	8.07 Bn
10	Medicus Pharma	7.87 Mn	7.98 Mn	-

Download Data